Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0PO9P
|
|||
Drug Name |
EIDD-2801
|
|||
Synonyms |
EIDD-2801 compound
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H19N3O7
|
|||
Canonical SMILES |
CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O
|
|||
InChI |
1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1
|
|||
InChIKey |
HTNPEHXGEKVIHG-QCNRFFRDSA-N
|
|||
CAS Number |
CAS 2349386-89-4
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | An Orally Bioavailable Broad-Spectrum Antiviral Inhibits SARS-CoV-2 in Human Airway Epithelial Cell Cultures and Multiple Coronaviruses in Mice. Sci Transl Med. 2020 Apr 6;eabb5883. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.